The involvement of NaV1.2 in human disease has been highlighted by the identification of over 20 non-/mis-sense mutations in SCN2A in patients with seizure disorders, including BFNIS, GEFS+ 5,22,25,50,51. Here, SCN2A is linked to epilepsy.